[go: up one dir, main page]

Nakagawa et al., 1975 - Google Patents

Effect of taurine on alteration in adrenal functions induced by stress

Nakagawa et al., 1975

View PDF
Document ID
16854480236336012350
Author
Nakagawa K
Kuriyama K
Publication year
Publication venue
The Japanese Journal of Pharmacology

External Links

Snippet

When rats were exposed to immobilized cold stress, adrenaline content in the adrenal gland as well as noradrenaline content in the brain stem were reduced drastically, while noradrenaline content in the atria was not altered by the application of stress. Oral …
Continue reading at www.jstage.jst.go.jp (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epihephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Similar Documents

Publication Publication Date Title
Nakagawa et al. Effect of taurine on alteration in adrenal functions induced by stress
Mueller et al. Increase in tyrosine hydroxylase activity after reserpine administration
Weiner et al. Modification of Norepinephrine Synthesis in Intact Tissue by Drugs and during Shor-term Adrenergic Nerve Stimulation
Laiz‐carrión et al. Influence of cortisol on osmoregulation and energy metabolism in gilthead seabream Sparus aurata
Thoenen et al. Selective induction by nerve growth factor of tyrosine hydroxylase and dopamine-β-hydroxylase in the rat superior cervical ganglia
Jahangir et al. Increased calcium vulnerability of senescent cardiac mitochondria: protective role for a mitochondrial potassium channel opener
Reis et al. Brain dopamine‐β‐hydroxylase: regional distribution and effects of lesions and 6‐hydroxy‐dopamine on activity
Reiter Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences
Öner-Iyidogan et al. The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes
Love et al. INFLUENCE OF ISOPROTERENOL AND 1-(2', 4'-DICHLOROPHENYL)-2-t-BUTYLAMINOETHANOL (DCB) ON FREE FATTY ACID RELEASE AND GLUCOSE METABOLISM IN ADIPOSE TISSUE
Fedotcheva et al. Protectors of the mitochondrial permeability transition pore activated by iron and doxorubicin
CA2254116C (en) Method and composition for the treatment of lipid and glucose metabolism disorders
Bagley et al. The activities of rat hepatic cysteine dioxygenase and cysteinesulfinate decarboxylase are regulated in a reciprocal manner in response to dietary casein level
Rigual et al. Synthesis and release of catecholamines by the cat carotid body in vitro: effects of hypoxic stimulation
Magos The effects of carbon disulphide exposure on brain catecholamines in rats
Young et al. Evidence for cyclic AMP‐mediated increase of aromatic L‐amino acid decarboxylase activity in the striatum and midbrain
Boros et al. Oxygen free radical-induced histamine release during intestinal ischemia and reperfusion
Alonso et al. Tyrosine loading enhances catecholamine excretion by rats
Greengard et al. Effects of irradiation and starvation on the regulation of rat liver enzymes.
El-Khatib et al. Effects of aminoguanidine and desferrioxamine on some vascular and biochemical changes associated with streptozotocin-induced hyperglycaemia in rats
Lores Arnaiz et al. Regional vulnerability to oxidative stress in a model of experimental epilepsy
Squires EVIDENCE THAT 5‐METHOXY‐N, N‐DIMETHYL TRYPTAMINE IS A SPECIFIC SUBSTRATE FOR MAO‐A IN THE RAT: IMPLICATIONS FOR THE INDOLEAMINE DEPENDENT BEHAVIOURAL SYNDROME
Mei et al. Age-related reductions in the activities of antioxidant enzymes in the rat inferior colliculus
Geng et al. Protective effects of pyridoxal phosphate against glucose deprivation‐induced damage in cultured hippocampal neurons
Powell et al. The fate of sulfate esters in vivo